NewAmsterdam Pharma

Biotechnology

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated.

NAMS

Visualizar Fundamentos

NewAmsterdam Pharma

6,8

P/B

128,2

P/S

—

P/EBITDA

—

Forward P/E

3,2

BVPS

—

EPS